Ingredient Screening
What it does
Given an efficacy goal (“inhibit melanogenesis”, “improve barrier function”, “lower postprandial glucose”), it produces a set of candidates worth pursuing, each with a stated reason for being on the list.
How it works
- Anchor the mechanism — resolve the goal to concrete targets and pathways instead of stopping at “antioxidant”.
- List candidates — from the knowledge graph, INCI libraries, ethnobotanical leads, and analysis of existing products.
- Evidence the mechanism — literature, clinical trials, and patents; key claims pass evidence grading.
- Safety and regulatory gates — safety data, adverse events, additive/supplement registry status, target-market compliance.
- Feasibility — supplier availability, retail eligibility, known product precedent, co-formulation precedent.
- Rank and self-audit — order by evidence strength and feasibility, then audit the list for weak evidence dressed up as strong.
What you get
A prioritized shortlist (ingredient, mechanism, evidence grade, safety and regulatory status, supply), the rationale behind each inclusion or exclusion, a bibliography, and optionally a deck.
Limits
- Computational predictions (docking, similarity, connectivity analysis) inform ranking; they are not proof of activity.
- The shortlist is an R&D starting point, not a purchasing decision — bench validation and commercial confirmation still apply.
Orphic